DK0988797T3 - Anvendelse af præparater til mineraltilførsel efter gastrektomia - Google Patents

Anvendelse af præparater til mineraltilførsel efter gastrektomia

Info

Publication number
DK0988797T3
DK0988797T3 DK97944085T DK97944085T DK0988797T3 DK 0988797 T3 DK0988797 T3 DK 0988797T3 DK 97944085 T DK97944085 T DK 97944085T DK 97944085 T DK97944085 T DK 97944085T DK 0988797 T3 DK0988797 T3 DK 0988797T3
Authority
DK
Denmark
Prior art keywords
gastrectomy
mineral
delivery preparations
postgastrectomic
mineral delivery
Prior art date
Application number
DK97944085T
Other languages
English (en)
Inventor
Bioscience Labs Ohtsuki Masako
Bioscience Labs Ohta Atsutane
Food Res Development La Toshio
Bioscience Labs Adachi Takashi
Original Assignee
Meiji Seika Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Co filed Critical Meiji Seika Co
Application granted granted Critical
Publication of DK0988797T3 publication Critical patent/DK0988797T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK97944085T 1996-10-08 1997-10-08 Anvendelse af præparater til mineraltilførsel efter gastrektomia DK0988797T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8267096A JPH10108647A (ja) 1996-10-08 1996-10-08 胃切除術後患者用ミネラル補給材
PCT/JP1997/003597 WO1998015196A1 (en) 1996-10-08 1997-10-08 Compositions for postgastrectomic mineral supply

Publications (1)

Publication Number Publication Date
DK0988797T3 true DK0988797T3 (da) 2004-04-13

Family

ID=17440006

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944085T DK0988797T3 (da) 1996-10-08 1997-10-08 Anvendelse af præparater til mineraltilførsel efter gastrektomia

Country Status (10)

Country Link
US (1) US6197758B1 (da)
EP (1) EP0988797B1 (da)
JP (2) JPH10108647A (da)
AT (1) ATE260051T1 (da)
AU (1) AU4570897A (da)
CA (1) CA2267932C (da)
DE (1) DE69727839T2 (da)
DK (1) DK0988797T3 (da)
ES (1) ES2213838T3 (da)
WO (1) WO1998015196A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
JP2001064181A (ja) * 1999-08-27 2001-03-13 Otsuka Pharmaceut Co Ltd 免疫賦活組成物
US20030004211A1 (en) * 2001-05-25 2003-01-02 Frank Corsini Carbohydrate modifying agent and drinks containing the modifying agent
WO2002096451A1 (en) * 2001-05-25 2002-12-05 University Of Scranton Carbohydrate modifying agent and drinks containing the modifying agent
US20030017219A1 (en) * 2001-05-25 2003-01-23 Frank Corsini Carbohydrate modifying agent and drinks containing the modifying agent
JP2003334030A (ja) * 2002-05-22 2003-11-25 Toyo Shinyaku:Kk 健康食品
DK1538924T3 (da) * 2002-08-30 2008-02-04 Campina Bv Skummende ingrediens og produkter indeholdende ingrediensen
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1721611A1 (en) * 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
CA2570208A1 (en) * 2004-06-22 2005-12-29 N.V. Nutricia Improvement of barrier integrity in hiv patients
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
JP4588403B2 (ja) * 2004-10-04 2010-12-01 森永乳業株式会社 カルシウム・マグネシウム含有組成物の製造方法
JP4693390B2 (ja) * 2004-11-09 2011-06-01 五洲薬品株式会社 機能性付加水とその製造方法
ATE471665T1 (de) * 2005-04-21 2010-07-15 Nutricia Nv Nahrungsergänzungsmittel für hiv-patienten
UA92052C2 (ru) * 2005-12-07 2010-09-27 Нікомед Фарма Ас Предварительно уплотненные кальциесодержащие композиции
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
MX2009011696A (es) * 2007-05-23 2009-11-10 Tate & Lyle Ingredients Composicion comestible que comprende una composicion de oligosacarido resistente a la digestion o lentamente digestible.
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
WO2009096772A1 (en) * 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
EP2400839B1 (en) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CN109293802B (zh) * 2018-09-13 2020-11-03 福建农林大学 一种琼胶寡糖铁及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES360433A1 (es) * 1968-11-20 1970-11-16 Rocador Sa Procedimiento para la fabricacion de un compuesto de hierrotrivalente apropiado para administracion por via oral.
JPS57156419A (en) 1981-03-24 1982-09-27 Kyowa Chem Ind Co Ltd Remedy for sideropenia
JPS59199626A (ja) 1983-04-26 1984-11-12 Terumo Corp 糖質輸液
EP0343703A3 (en) * 1988-05-26 1990-06-06 The Procter & Gamble Company Mineral supplements with sugar alcohols
JPH0367565A (ja) * 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化食品
JPH0367571A (ja) * 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化清涼飲料水
US5439882A (en) * 1989-12-29 1995-08-08 Texas Tech University Health Sciences Center Blood substitute
JP3179090B2 (ja) * 1990-09-25 2001-06-25 日新製糖株式会社 カルシウム吸収促進剤
JPH04349868A (ja) * 1991-05-29 1992-12-04 Asahi Chem Ind Co Ltd ミネラル吸収促進剤
JP2920434B2 (ja) 1991-06-20 1999-07-19 東和化成工業株式会社 カルシウム及び食物繊維含有飲食物とその製造方法
JPH06116154A (ja) 1992-02-28 1994-04-26 Yamanouchi Pharmaceut Co Ltd 骨粗鬆症の予防治療用組成物
TW293036B (da) * 1992-11-27 1996-12-11 Takeda Pharm Industry Co Ltd
JP2596509B2 (ja) * 1992-12-11 1997-04-02 雪印乳業株式会社 新規なグルクロン酸含有オリゴ糖、その製造法及びその利用
JP3279695B2 (ja) * 1993-01-08 2002-04-30 雪印乳業株式会社 分岐ガラクトオリゴ糖を有効成分とするミネラル吸収促進剤
JP3279694B2 (ja) * 1993-01-08 2002-04-30 雪印乳業株式会社 ラクチュロースオリゴ糖を有効成分とするミネラル吸収促進剤
JP3188583B2 (ja) * 1993-02-25 2001-07-16 明治製菓株式会社 マグネシウム補給材とその利用
JP3693359B2 (ja) * 1993-07-21 2005-09-07 マルハ株式会社 骨強化促進剤
JP3462535B2 (ja) * 1993-08-31 2003-11-05 サントリー株式会社 ミネラル吸収促進組成物
JP3024896B2 (ja) 1993-11-22 2000-03-27 明治製菓株式会社 貧血改善材
JP3850891B2 (ja) * 1994-03-01 2006-11-29 ゼリア新薬工業株式会社 緩下効果を有する組成物
JPH07252156A (ja) 1994-03-15 1995-10-03 Meiji Seika Kaisha Ltd 骨粗鬆症予防治療材
JP3396090B2 (ja) * 1994-08-18 2003-04-14 日東薬品工業株式会社 粉末栄養組成物
JPH08157379A (ja) 1994-12-02 1996-06-18 Meiji Seika Kaisha Ltd アレルギー予防材

Also Published As

Publication number Publication date
ES2213838T3 (es) 2004-09-01
EP0988797B1 (en) 2004-02-25
EP0988797A4 (en) 2001-10-04
DE69727839T2 (de) 2004-12-30
EP0988797A1 (en) 2000-03-29
ATE260051T1 (de) 2004-03-15
CA2267932C (en) 2007-11-27
AU4570897A (en) 1998-05-05
US6197758B1 (en) 2001-03-06
WO1998015196A1 (en) 1998-04-16
CA2267932A1 (en) 1998-04-16
JPH10108647A (ja) 1998-04-28
JP3933702B2 (ja) 2007-06-20
DE69727839D1 (de) 2004-04-01

Similar Documents

Publication Publication Date Title
DK0988797T3 (da) Anvendelse af præparater til mineraltilførsel efter gastrektomia
DE69626513D1 (en) Imidazolverbindungen
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
TR199901411T2 (xx) Analjezik etkili yeni bile�imler.
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
PA8486001A1 (es) Composiciones de celecoxib
BR0111196A (pt) Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
PL327735A1 (en) Novel substituted derivatives of imidazole
BR0009524A (pt) Uso de um composto, e, composição farmacêutica ou veterinaria
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
ATE232396T1 (de) Oxydiertes thymosin beta 4
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
DE58902712D1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
IL156798A0 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependency
CA2408541A1 (en) Treating eczema and/or psoriasis
AU8020698A (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
ZA966953B (en) Pharmaceutical composition.
BR0005010A (pt) Composição para tratamento de distúrbios de secreção externa exceto a hipolacrimação e seu uso
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
SE9301831D0 (sv) Pharmaceutical compositions